ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - dapagliflozin propanediol; metformin hydrochloride - טבליות עם שחרור נרחב - metformin hydrochloride 502.61 mg; dapagliflozin propanediol 6.150 mg - metformin and dapagliflozin

ישראל - עברית - Ministry of Health

boehringer ingelheim israel ltd. - linagliptin; metformin hydrochloride - טבליות מצופות פילם - metformin hydrochloride 500 mg; linagliptin 2.5 mg - metformin

ישראל - עברית - Ministry of Health

boehringer ingelheim israel ltd. - linagliptin; metformin hydrochloride - טבליות מצופות פילם - metformin hydrochloride 850 mg; linagliptin 2.5 mg - metformin

ישראל - עברית - Ministry of Health

merck serono ltd - metformin hydrochloride - טבליות בשחרור ממושך - metformin hydrochloride 1000 mg - metformin

ישראל - עברית - Ministry of Health

merck serono ltd - metformin hydrochloride - טבליות בשחרור ממושך - metformin hydrochloride 500 mg - metformin

ישראל - עברית - Ministry of Health

merck serono ltd - metformin hydrochloride - טבליות בשחרור ממושך - metformin hydrochloride 750 mg - metformin

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - metformin hydrochloride; sitagliptin - טבליות מצופות פילם - metformin hydrochloride 1000 mg; sitagliptin 50 mg - metformin and sitagliptin

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - metformin hydrochloride; sitagliptin - טבליות מצופות פילם - metformin hydrochloride 850 mg; sitagliptin 50 mg - metformin and sitagliptin

ישראל - עברית - Ministry of Health

novartis pharma services ag - metformin hydrochloride 850 mg; vildagliptin 50 mg - film coated tablets - metformin - eucreas is indicated in the treatment of type 2 diabetes mellitus:• eucreas is indicated in the treatment of type 2 diabetes patients who are unable to achieve sufficient glycemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.• eucreas is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulphonylurea.• eucreas is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.

ישראל - עברית - Ministry of Health

novo nordisk ltd - metformin hydrochloride 500 mg; repaglinide 1 mg - tablets - metformin - novogard is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 mellitus who are already treated with a meglitinide and metformin hcl or who have inadequate glycemic control on a meglitinide alone or metformin hcl alone.